Omeros (OMER) Revenue (2010 - 2026)

Omeros' (OMER) quarterly Revenue came in at $9.9 million in Q1 2026, down 67.03% quarter-over-quarter from $30.0 million in Q3 2021.

Omeros (OMER) Revenue (2010 - 2026) Analysis & Trends

Omeros has disclosed Revenue across 13 years of filings, most recently posting $9.9 million for Q1 2026.

Revenue for Q1 2026 came in at $9.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $68.7 million (down 13.98% YoY), and the FY2020 annual result was $73.8 million, down 33.98% from the prior year.
Revenue came in at $9.9 million for Q1 2026 at Omeros, down from $30.0 million in the prior quarter.
In the past five years, Revenue ranged from a high of $9.9 million in Q1 2026 to a low of $9.9 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	5.21 Mn
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	306.30 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	2.99 Bn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Omeros	737.87 Mn	602.55 Mn	9.31 Mn	9.89 Mn

Download Data